Personality Disorders and Addiction (July/August)

Date of Issue: 07/01/2022 | Volume: 10 | Number: 5

Issue Links:Learning Objectives | Editorial Information

Dr. Pierson explores the relationship between borderline personality disorder and substance use and describes treatment approaches for patients with comorbid personality disorder and addiction. We describe an emerging approach to reduce opioid overdose deaths: supervised drug consumption sites. Plus, updates on some of the latest research on smoking cessation, alcohol use disorder, and problem gambling.

In This Issue

Clinical Update

Supervised Drug Consumption

Topics: Harm reduction | Opioid epidemic | Safe Consumption Site

Supervised Consumption Sites are clinical settings where patients can use drugs in as safe a manner as possible. Clients are supplied with sterile equipment and the clinics are staffed by medical professionals who can respond in the case of an overdose. Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

Read More
Expert Q&A

Addiction and Borderline Personality Disorder

Topics: Borderline Personality Disorder | Comorbidity | Dialectical Behavioral Therapy | Psychotherapy

Borderline personality disorder is highly comorbid with substance use disorders for reasons that are described by Dr. Pierson. She also reviews some basics of dialectical behavioral therapy, the gold standard treatment for borderline personality disorder, and shows us how therapeutic principles can be applied the treatment of addiction.

Read More
Research Update

Should Prolonged Abstinence From Alcohol Be Required Before Liver Transplant?

Topics: Alcohol use disorder | alcohol- associated liver disease | consult-liaison | medical comorbidity | transplant surgery

Patients with alcohol-associated liver disease have traditionally needed to demonstrate an ability to refrain from drinking for 6 months before being deemed eligible for a liver transplant, despite the absence of research findings to support this requirement. Findings from this retrospective study show that a waiting period is not associated with improved outcomes.

Read More
Research Update

Does Pioglitazone Lead to Reduced Alcohol Use?

Topics: Alcohol use disorder | Medication

The hunt continues for effective medications for alcohol use disorder. Researchers here investigated the potential utility pioglitazone, a medication commonly used for diabetes management.

Read More
Research Update

E-Cigarettes and Relapse to Cigarette Smoking

Topics: E-Cigarettes | Smoking Cessation | Vaping

Evidence for the use of e-cigarettes as smoking cessation agents continues to evolve. In this observational study, researchers find that e-cigarettes modestly increase the risk of relapse to smoking in patients who have managed to quit.

Read More
CME Post-Test

CME Post-Test - Personality Disorders and Addiction, CATR, July/August 2022

Topics: CME Post-Test

Read More